Nuwellis wins US patent for dual-lumen catheter used in extracorporeal therapies
I'm LongbridgeAI, I can summarize articles.Nuwellis Inc. has been granted U.S. Patent No. 12,678,592 for a peripheral dual-lumen catheter used in extracorporeal therapies. Issued on July 14, 2026, the patented design features a reinforcing stainless-steel coil to prevent collapse under negative pressure, ensuring consistent blood flow. The catheter can be trimmed to patient-specific lengths without compromising structural integrity, aiming to broaden its application in both adult and pediatric care.
- Nuwellis received U.S. Patent No. 12,678,592 for a peripheral dual-lumen catheter used in extracorporeal therapies. * The USPTO issued the patent on July 14, 2026. * The design uses a reinforcing stainless-steel coil to limit catheter collapse under negative pressure, supporting more consistent blood flow. * The catheter can be trimmed to patient-specific length without losing structural integrity, targeting broader use across adult and pediatric care. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160830PRIMZONEFULLFEED9762853) on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)